We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

3 hedge funds and large institutions have $35.4M invested in Plus Therapeutics in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $33.4M → $35.4M (+$2.02M)

0% more funds holding

Funds holding: 3 → 3 (0)

65% less call options, than puts

Call options by funds: $178K | Put options by funds: $511K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$178K
Puts
$511K
Net Calls
-$333K
Net Calls Change
+$45K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$847K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$295K
3
UOC
UBS O'Connor
Illinois
-$175K
4
ProShare Advisors
ProShare Advisors
Maryland
-$148K
5
AC
Amici Capital
New York
-$70K
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
– -$295K – –
Jennison Associates
77
Jennison Associates
New York
– -$847K – –
JP Morgan Chase
78
JP Morgan Chase
New York
– -$34K – –
Mariner
79
Mariner
Kansas
– -$28K – –
Mitsubishi UFJ Asset Management
80
Mitsubishi UFJ Asset Management
Japan
– -$35K – –
Nomura Holdings
81
Nomura Holdings
Japan
– -$53K – –
ProShare Advisors
82
ProShare Advisors
Maryland
– -$148K – –
RFC
83
Russell Frank Company
Washington
– -$50K – –
SG Americas Securities
84
SG Americas Securities
New York
– -$27K – –
UOC
85
UBS O'Connor
Illinois
– -$175K – –
1 2 3
4

PSTV Hedge Fund Activity: Q4 2013 in Review

3 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2013, worth a combined $35.4M — up 6.1% from $33.4M a quarter earlier.

Fund positioning in PSTV was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Jennison Associates, cutting an estimated $847K.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $35.4M of Plus Therapeutics stock for Q4 2013, up 6.1% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q4 2013 and 0 closed out.
  • The largest Plus Therapeutics seller in Q4 2013 was Jennison Associates, an estimated $847K sold.

Based on aggregated 13F filings for Q4 2013.